White Pine Capital LLC purchased a new stake in Transcat, Inc. (NASDAQ:TRNS – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 19,335 shares of the scientific and technical instruments company’s stock, valued at approximately $1,710,000. White Pine Capital LLC owned approximately 0.21% of Transcat as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Integrated Wealth Concepts LLC purchased a new stake in Transcat during the 2nd quarter worth about $32,000. Persistent Asset Partners Ltd bought a new position in Transcat in the 2nd quarter worth about $52,000. GAMMA Investing LLC grew its holdings in Transcat by 133.6% during the 3rd quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock valued at $91,000 after buying an additional 589 shares in the last quarter. Squarepoint Ops LLC grew its holdings in Transcat by 9.0% during the 2nd quarter. Squarepoint Ops LLC now owns 8,794 shares of the scientific and technical instruments company’s stock valued at $816,000 after buying an additional 728 shares in the last quarter. Finally, Corient Private Wealth LP grew its holdings in Transcat by 9.1% during the 2nd quarter. Corient Private Wealth LP now owns 9,509 shares of the scientific and technical instruments company’s stock valued at $882,000 after buying an additional 791 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors.
Transcat Price Performance
NASDAQ:TRNS opened at $104.08 on Monday. The firm has a market capitalization of $978.35 million, a price-to-earnings ratio of 216.84 and a beta of 0.61. Transcat, Inc. has a 52-week low of $50.23 and a 52-week high of $112.44. The stock has a fifty day moving average of $89.01 and a 200 day moving average of $83.53. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.19 and a current ratio of 2.57.
Transcat (NASDAQ:TRNS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.45 by $0.19. The business had revenue of $97.09 million during the quarter, compared to analysts’ expectations of $92.46 million. Transcat had a return on equity of 6.14% and a net margin of 1.26%. On average, research analysts expect that Transcat, Inc. will post 2.06 EPS for the current fiscal year.
Analysts Set New Price Targets
Several brokerages have recently weighed in on TRNS. Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 5th. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Northland Securities raised shares of Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 price objective for the company in a research note on Wednesday, October 21st. CJS Securities began coverage on shares of Transcat in a research note on Tuesday, October 27th. They set an “outperform” rating and a $115.00 price objective for the company. Finally, Oppenheimer raised shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price on the stock in a report on Wednesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $108.33.
View Our Latest Analysis on Transcat
Insider Buying and Selling at Transcat
In other Transcat news, CEO Jaime A. Irick purchased 2,275 shares of the company’s stock in a transaction dated Thursday, November 5th. The stock was purchased at an average price of $101.26 per share, for a total transaction of $230,366.50. Following the transaction, the chief executive officer owned 2,275 shares in the company, valued at $230,366.50. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.80% of the stock is currently owned by insiders.
About Transcat
Transcat, Inc. provides calibration and related services, including instrument repair, inspection and compliance support. Its services help customers maintain the accuracy and reliability of equipment used in regulated and quality-sensitive operations. The company also distributes professional-grade test, measurement and control instruments from a range of manufacturers. Its offerings include equipment used to measure and monitor variables such as pressure, temperature, electrical signals and humidity.
Read More
- Five stocks we like better than Transcat
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
